Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at Yumanity Therapeutics

Zippia score 4.3

Overview

SalaryRevenue

Reviews

DemographicsCEO & Executives

Yumanity Therapeutics overview

Industry
Pharmaceutical
Revenue
$1.9B
Headquarters
Employees
23,876
Founded in
Organization type
Public
CEO
Meenu Chhabra
Social media
Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, are designed to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Yumanity Therapeutics is a relatively young company. It was founded only in 2014. This emerging company loves to hire graduates from Knox College, with 8.3% of its employees having attended Knox College. If you want to check out some more established companies, you can find other great places to work on Zippia's list of Best Companies to Work For in Cambridge, MA.The average employee at Yumanity Therapeutics makes $96,863 per year, which is competitive for its industry and location. Some of its highest paying competitors, Vertex Pharmaceuticals, Lexicon Pharmaceuticals, and AVEO Oncology, pay $95,952, $81,955, and $74,270, respectively.
Based in Cambridge, MA, Yumanity Therapeutics is an industry leader with 23,876 employees and an annual revenue of $1.9B.

Yumanity Therapeutics's mission statement

To improve the lives of patients with cystic fibrosis.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

Yumanity Therapeutics employee reviews

Be the first to review!

Do you work at Yumanity Therapeutics?

Help job seekers learn about working at Yumanity Therapeutics

On this page

Be the first to review Yumanity Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Yumanity Therapeutics?

The team at Yumanity Therapeutics

  • The founders of Yumanity Therapeutics are Jeffery Kelly and Richard Morimoto.
  • The key people at Yumanity Therapeutics are Meenu Chhabra, Jeffery Kelly and Richard Morimoto.
Key people
Meenu Chhabra
Jeffery Kelly
Richard Morimoto

Yumanity Therapeutics rankings

Yumanity Therapeutics is ranked #40 on the Best Pharmaceutical companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Yumanity Therapeutics salaries

Average Yumanity Therapeutics salary
$96,863
yearly
$46.57 hourly
Updated March 14, 2024

Rate the fairness of Yumanity Therapeutics' compensation policies.

Zippia waving zebra

Yumanity Therapeutics diversity

7.4
Diversity score
We calculated Yumanity Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Yumanity Therapeutics’s workforce.
Yumanity Therapeutics diversity summary. Zippia estimates Yumanity Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Yumanity Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Yumanity Therapeutics's workforce.
  • Yumanity Therapeutics has 23,876 employees.
  • 36% of Yumanity Therapeutics employees are women, while 64% are men.
  • The most common ethnicity at Yumanity Therapeutics is White (53%).
  • 25% of Yumanity Therapeutics employees are Asian.
  • 12% of Yumanity Therapeutics employees are Hispanic or Latino.
  • The average employee at Yumanity Therapeutics makes $96,863 per year.
  • Employees at Yumanity Therapeutics stay with the company for 3.8 years on average.

Do you work at Yumanity Therapeutics?

Is Yumanity Therapeutics' workforce diverse and inclusive?

Yumanity Therapeutics financial performance

8.6
Performance score

Yumanity Therapeutics annual revenue

$2B
$1B
$1B
$747M
$373M
$0
2015
2016

Are you an executive, HR leader, or brand manager at Yumanity Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Yumanity Therapeutics FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Cities with Yumanity Therapeutics jobs

Related companies

Related company jobs

Related company salaries

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of Yumanity Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Yumanity Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Yumanity Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Yumanity Therapeutics. The data presented on this page does not represent the view of Yumanity Therapeutics and its employees or that of Zippia.

    Yumanity Therapeutics may also be known as or be related to PROTEOSTASIS THERAPEUTICS, INC., Proteostasis Therapeutics, Proteostasis Therapeutics Inc, Proteostasis Therapeutics, Inc. and Yumanity Therapeutics.